​

Funding Round

Series F - Atox Bio

Series F - Atox Bio

Investment Firm

Overview

Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.

Announced Date

Dec 04, 2017

Funding Type

Series F

Highlights

Location

Asia

Social

Investor Lead

Arix Bioscience

Arix Bioscience

Arix Bioscience is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

7

Investor Name
Participant InvestorAsahi Kasei
Participant InvestorArix Bioscience
Participant InvestorOrbiMed
Participant InvestorSR One
Participant InvestorAdams Street Partners

Round Details and Background

Atox Bio raised $30000000 on 2017-12-04 in Series F

Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 04, 2017
Series F - Atox Bio
8-30.0M
Oct 13, 2010
Venture Round - Atox Bio
-2.1M
Jul 24, 2014
Series E - Atox Bio
3-23.0M
Dec 19, 2011
Series A - Atox Bio
1-3.3M

Recent Activity

There is no recent news or activity for this profile.